At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
ROTEM +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of ROTEM Intraoperatively in Women With Placenta Accreta
In Brief
A clinical study evaluating ROTEM and standard treatment for Placenta Accreta. Completed, enrolled 32 participants.
Detailed Summary
This study evaluates the use of rapid tests for hematocrit and clotting function in women undergoing surgery for placenta accreta. Half of participants will have these rapid tests performed during surgery to guide blood product transfusion and the other half will have standard lab tests performed to guide transfusion.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlacenta Accreta
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartMay 2016
Primary CompletionDec 2024
Study CompletionDec 2025
TodayJul 2026
First PostedApr 6, 2016
Enrollment StartMay 8, 2016
Primary CompletionDec 1, 2024
Study CompletionDec 1, 2025
TodayJul 2, 2026
Enrollment to primary: 8.6 yearsPosted 10.2 years ago
Interventions
ROTEMprocedure
rapid testing of blood clot formation
standard treatmentprocedure
visual assessment of blood loss and clotting function every 30 minutes, combined with standard laboratory testing when indicated